Literature DB >> 3495805

Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene.

P A Sherman, P V Basta, J P Ting.   

Abstract

We have used in vitro deletion mutagenesis in combination with DNA transfection to search for cis-acting regulatory elements involved in the tissue-specific expression of a human class II major histocompatibility complex gene. A 140-base-pair 5' flanking fragment that contains the class II box consensus sequences and an octamer sequence (ATTTGCAT) confers tissue specificity on the promoter of the HLA-DR alpha gene. Recombinant DNA plasmids containing this DR alpha gene segment fused to the coding sequence of the bacterial chloramphenicol acetyltransferase gene are expressed at higher levels in human B-cell lines than in human T-cell lines. We have demonstrated that the most 5' of the class II boxes is essential for tissue-specific DR alpha promoter function. In addition, using an electrophoretic mobility shift assay to identify DNA binding proteins, we have detected binding of nuclear proteins to DNA probes containing the class II boxes and the octamer sequence. A protein that binds to the octamer is present at higher levels in nuclear extracts of B-cell lines than in other cell lines examined. This protein may be important for the tissue-specific expression of the HLA-DR alpha gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495805      PMCID: PMC305063          DOI: 10.1073/pnas.84.12.4254

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  Structure of the human Ia-associated invariant (gamma)-chain gene: identification of 5' sequences shared with major histocompatibility complex class II genes.

Authors:  D M O'Sullivan; D Larhammar; M C Wilson; P A Peterson; V Quaranta
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes.

Authors:  H L Sive; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Characterization of an HLA DR beta pseudogene.

Authors:  D Larhammar; B Servenius; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma.

Authors:  R S Accolla; G Carra; J Guardiola
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  An enhancer-like sequence within the Xenopus U2 gene promoter facilitates the formation of stable transcription complexes.

Authors:  I W Mattaj; S Lienhard; J Jiricny; E M De Robertis
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

7.  Two regulatory elements for immunoglobulin kappa light chain gene expression.

Authors:  Y Bergman; D Rice; R Grosschedl; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Orientation-dependent transcriptional activator upstream of a human U2 snRNA gene.

Authors:  M Ares; M Mangin; A M Weiner
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

9.  The two embryonic U1 RNA genes of Xenopus laevis have both common and gene-specific transcription signals.

Authors:  A Krol; E Lund; J E Dahlberg
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

10.  Transcription signals in embryonic Xenopus laevis U1 RNA genes.

Authors:  G Ciliberto; R Buckland; R Cortese; L Philipson
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  62 in total

Review 1.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.

Authors:  J P Cogswell; P V Basta; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Conservation of the promoter region of DRA-like genes from nonhuman primates.

Authors:  L K Gaur; E R Heise; J P Ting
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene.

Authors:  N J Zeleznik-Le; J C Azizkhan; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  Regulatory factor-X binding to mutant HLA-DRA promoter sequences.

Authors:  S L Hasegawa; J H Sloan; W Reith; B Mach; J M Boss
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

9.  Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function.

Authors:  B J Vilen; J P Cogswell; J P Ting
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

10.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.